ILF3 and melanoma: Interleukin enhancer-binding factor 3-antisense RNA 1 (ILF3-AS1) has been found upregulated in melanoma tissues and cell lines, compared with normal counterparts, and its increased expression in melanoma patients is associated with metastatic characteristics and poor prognosis (Chen et al., 2017b).